Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Context and Objective: Spillover of fatty acids (FAs) into the plasma non-esterified fatty acid (NEFA) pool, due to an inability of adipose tissue to accommodate sufficient fat uptake, has been suggested to be a contributing factor to insulin resistance in obesity. Using specific labelling techniques, we compared the proportion of spillover-derived NEFA across a range of adiposity. Participants and Methods: Seventy-one healthy men and women (22-64 years; BMI 20-35 kg/m2) were fed a mixed meal (40g fat) containing [U13C]palmitate to assess the contribution of chylomicron-derived spillover FAs. To investigate subcutaneous abdominal-specific spillover, arterio-venous difference and stable-isotope methodologies were used in sub-study (6 men, 6 women). Results: Chylomicron-derived FA spillover was significantly higher in individuals with a BMI <25kg/m2 (n=18) compared to those with a BMI ≥25kg/m2 (n=53) (22.2±1.6% vs 18.6±0.7%, P=0.02). Women had significantly higher chylomicron-derived FA spillover than age and BMI matched men (21.9±1.1% vs. 15.0±1.6%, P=0.001). Assessing spillover across subcutaneous abdominal adipose tissue showed significantly higher proportions in women than in men (28.5±6.1% vs. 9.9±1.3%, P=0.01). Conclusion: These data demonstrate that there is a considerable degree of spillover FAs into the systemic NEFA pool in the postprandial state; this process is greater and more dynamic in lean individuals and women. Contrary to general perception, spillover of chylomicron-derived FA into systemic circulation is a physiologically normal feature most easily observed in people with a higher capacity for clearance of plasma triglyceride but does not appear to be a pathway providing excess NEFA in people with obesity.

Original publication

DOI

10.1210/jc.2017-01517

Type

Journal article

Journal

J Clin Endocrinol Metab

Publication Date

01/11/2017